LeonaBio (LONA) Share-based Compensation (2019 - 2026)

LeonaBio (LONA) has 8 years of Share-based Compensation data on file, last reported at $662000.0 in Q1 2026.

• Quarterly Share-based Compensation fell 59.56% year-over-year to $662000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 48.77% YoY) and the FY2025 annual result came in at $6.1 million, down 44.77% from the prior year.
• Share-based Compensation retreated to $662000.0 in Q1 2026 per LONA's latest filing, from $1.5 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $3.2 million in Q2 2024 and bottomed at $662000.0 in Q1 2026.
• The 5-year median for Share-based Compensation is $2.4 million (2022), against an average of $2.3 million.
• The widest annual swing landed in 2022, when Share-based Compensation soared 180.39%; it then plunged 59.56% in 2026.
• Tracing LONA's Share-based Compensation over 5 years: stood at $2.4 million in 2022, then fell by 5.59% to $2.2 million in 2023, then climbed by 0.04% to $2.2 million in 2024, then tumbled by 34.59% to $1.5 million in 2025, then slumped by 54.6% to $662000.0 in 2026.
• Per Business Quant, the three latest LONA Share-based Compensation figures stand at $662000.0 (Q1 2026), $1.5 million (Q4 2025), and $1.4 million (Q3 2025).

Peer Comparison